title: Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer.
authors.affiliation: Medical Oncology Department, Hospital Universitario La Paz, IDIPAZ, Pº de Castellana 261, 28046 Madrid, Spain. jfeliu.hulp@salud.madrid.org
authors.forename: J
authors.initials: J
authors.lastname: Feliu
authors.forename: P
authors.initials: P
authors.lastname: Borrega
authors.forename: A
authors.initials: A
authors.lastname: León
authors.forename: L
authors.initials: L
authors.lastname: López-Gómez
authors.forename: M
authors.initials: M
authors.lastname: López
authors.forename: J
authors.initials: J
authors.lastname: Castro
authors.forename: C
authors.initials: C
authors.lastname: Belda-Iniesta
authors.forename: J
authors.initials: J
authors.lastname: Barriuso
authors.forename: V
authors.initials: V
authors.lastname: Martínez
authors.forename: M
authors.initials: M
authors.lastname: González-Barón